# SAMe to Treat Biliary Cirrhosis Symptoms

> **NCT00125281** · PHASE2 · TERMINATED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 50 (—)

## Conditions studied

- Liver Cirrhosis, Biliary

## Interventions

- **DRUG:** S-adenosyl-methionine (SAMe) capsules

## Key facts

- **NCT ID:** NCT00125281
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07-25
- **Primary completion:** 2007-07-31
- **Final completion:** 2008-07-02
- **Target enrollment:** 50 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125281, "SAMe to Treat Biliary Cirrhosis Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00125281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*